The PPAR signaling pathway, mitogen-activated protein kinase signaling pathway, P53 signaling pathway, and mTOR signaling pathway were associated with high risk in BLCA patients, whereas immune-related pathways were significantly enriched in a low-risk group (14). This evidence concerns the gene PPARA and bladder transitional cell carcinoma.